57624 Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices

inspection and testing of the company’s

physical security systems, audits of the

company’s records, verification of the

company’s compliance with state and

local laws, and a review of the

company’s background and history.

Therefore, pursuant to 21 U.S.C. 823

and 28 CFR 0.100 and 0.104, the Deputy

Assistant Administrator, Office of

Diversion Control, hereby orders that

the application submitted by the above

firm for registration as a bulk

manufacturer of the basic classes of

controlled substances listed above is

granted.

August 18, 2000.

John H. King,

Deputy Assistant Administrator Office of

Diversion Control Drug Enforcement

Administration.

[FR Doc. 00–24562 Filed 9–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[DEA #186F]

Controlled Substances: 2000

Aggregate Production Quotas

AGENCY: Drug Enforcement

Administration (DEA), Justice.

ACTION: Notice of final 2000 aggregate

production quotas.

SUMMARY: This notice establishes final

2000 aggregate production quotas for

controlled substances in Schedules I

and II of the Controlled Substances Act

(CSA). The DEA has taken into

consideration comments received in

response to a notice of the proposed

revised aggregate production quotas for

2000 published July 19, 2000 (65 FR

44836).

EFFECTIVE DATE: September 25, 2000.

FOR FURTHER INFORMATION CONTACT:

Frank L. Sapienza, Chief, Drug and

Chemical Evaluation Section, Drug

Enforcement Administration,

Washington, DC 20537, Telephone:

(202) 307–7183.

SUPPLEMENTARY INFORMATION: Section

306 of the CSA (21 U.S.C. 826) requires

that the Attorney General establish

aggregate production quotas for each

basic class of controlled substance listed

in Schedules I and II. This

responsibility has been delegated to the

Administrator of the DEA by Section

0.100 of Title 28 of the Code of Federal

Regulations. The Administrator, in turn,

has redelegated this function to the

Deputy Administrator of the DEA

pursuant to Section 0.104 of Title 28 of

the Code of Federal Regulations.

On July 19, 2000, a notice of the

proposed revised 2000 aggregate

production quotas for certain controlled

substances in Schedules I and II was

published in the Federal Register (65

FR 44836). All interested parties were

invited to comment on or object to these

proposed aggregate production quotas

on or before August 18, 2000.

Several companies and one individual

commented that the revised aggregate

production quotas for amphetamine,

codeine (for sale), dextropropoxyphene,

dihydrocodeine, hydrocodone (for sale),

hydromorphone, meperidine,

methadone intermediate,

methylphenidate, opium, oxycodone

(for sale), oxycodone (for conversion),

oxymorphone, pentobarbital,

phenylacetone, and

tetrahydrocannabinols were insufficient

to provide for the estimated medical,

scientific, research and industrial needs

of the United States, for export

requirements and for the establishment

and maintenance of reserve stocks.

DEA has taken into consideration the

above comments along with the relevant

1999 year-end inventories, initial 2000

manufacturing quotas, 2000 export

requirements, and actual and projected

2000 sales. Based on this information,

the DEA has adjusted the final 2000

aggregate production quotas for 4-

methoyxamphetamine, amphetamine,

dihydrocodeine, hydromorphone,

meperidine, methamphetamine,

oxycodone (for sale), oxycodone (for

conversion), oxymorphone and

pentobarbital to meet the legitimate

needs of the United States.

Regarding codeine (for sale),

dextropropoxyphene, hydrocodone (for

sale), methadone intermediate, opium,

methylphenidate, phenylacetone and

tetrahydrocannabinols, the DEA has

determined that no adjustments of the

aggregate production quotas are

necessary to meet the 2000 estimated

medical, scientific, research and

industrial needs of the United States.

Therefore, under the authority vested

in the Attorney General by Section 306

of the CSA of 1970 (21 U.S.C. 826),

delegated to the Administrator of the

DEA by Section 0.100 of Title 28 of the

Code of Federal Regulations, and

redelegated to the Deputy Administrator

pursuant to Section 0.104 of Title 28 of

the Code of Federal Regulations, the

Deputy Administrator hereby orders

that the final 2000 aggregate production

quotas for the following controlled

substances, expressed in grams of

anhydrous acid or base, be established

as follows:

Basic class

Established

final 2000

quotas

Schedule I:

2,5-Dimethoxyamphetamine ......................................................................................................................................................... 10,501,000

2,5-Dimethoxy-4-ethylamphetamine (DOET) ............................................................................................................................... 2

3-Methylfentanyl ........................................................................................................................................................................... 14

3-Methylthiofentanyl ...................................................................................................................................................................... 2

3,4-Methylenedioxyamphetamine (MDA) ..................................................................................................................................... 20

3,4-Methylenedioxy-N-ethylamphetamine (MDEA) ...................................................................................................................... 30

3,4-Methylenedioxymethamphetamine (MDMA) .......................................................................................................................... 20

3,4,5-Trimethoxyamphetamine ..................................................................................................................................................... 2

4-Bromo-2,5-Dimethoxyamphetamine (DOB) .............................................................................................................................. 2

4-Bromo-2,5-Dimethoxyphenethylamine (2 CB) .......................................................................................................................... 2

4-Methoxyamphetamine ............................................................................................................................................................... 251,000

4-Methylaminorex ......................................................................................................................................................................... 3

4-Methyl-2,5-Dimethoxyamphetamine (DOM) .............................................................................................................................. 2

5-Methoxy-3,4-Methylenedioxyamphetamine ............................................................................................................................... 2

Acetyl-alpha-methylfentanyl .......................................................................................................................................................... 2

Acetyldihydrocodeine .................................................................................................................................................................... 2

Acetylmethadol ............................................................................................................................................................................. 7

Allylprodine ................................................................................................................................................................................... 2

Alphacetylmethadol ...................................................................................................................................................................... 7

Alpha-ethyltryptamine ................................................................................................................................................................... 2

Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices 57625

Basic class

Established

final 2000

quotas

Alphameprodine ............................................................................................................................................................................ 2

Alphamethadol .............................................................................................................................................................................. 2

Alpha-methylfentanyl .................................................................................................................................................................... 2

Alpha-methylthiofentanyl .............................................................................................................................................................. 2

Aminorex ....................................................................................................................................................................................... 7

Benzylmorphine ............................................................................................................................................................................ 2

Betacetylmethadol ........................................................................................................................................................................ 2

Beta-hydroxy-3-methylfentanyl ..................................................................................................................................................... 2

Beta-hydroxyfentanyl .................................................................................................................................................................... 2

Betameprodine ............................................................................................................................................................................. 2

Betamethadol ................................................................................................................................................................................ 2

Betaprodine .................................................................................................................................................................................. 2

Bufotenine ..................................................................................................................................................................................... 2

Cathinone ..................................................................................................................................................................................... 9

Codeine-N-oxide ........................................................................................................................................................................... 2

Diethyltryptamine .......................................................................................................................................................................... 2

Difenoxin ....................................................................................................................................................................................... 10,000

Dihydromorphine .......................................................................................................................................................................... 508,000

Dimethyltryptamine ....................................................................................................................................................................... 3

Gamma-hydroxybutyric acid ......................................................................................................................................................... 15,000,000

Heroin ........................................................................................................................................................................................... 2

Hydroxypethidine .......................................................................................................................................................................... 2

Lysergic acid diethylamide (LSD) ................................................................................................................................................. 63

Mescaline ...................................................................................................................................................................................... 7

Methaqualone ............................................................................................................................................................................... 17

Methcathinone .............................................................................................................................................................................. 9

Morphine-N-oxide ......................................................................................................................................................................... 2

N,N-Dimethylamphetamine ........................................................................................................................................................... 7

N-Ethyl-1-Phenylcyclohexylamine (PCE) ..................................................................................................................................... 5

N-Ethylamphetamine .................................................................................................................................................................... 7

N-Hydroxy-3,4-Methylenedioxyamphetamine ............................................................................................................................... 2

Noracymethadol ............................................................................................................................................................................ 2

Norlevorphanol ............................................................................................................................................................................. 2

Normethadone .............................................................................................................................................................................. 7

Normorphine ................................................................................................................................................................................. 7

Para-fluorofentanyl ....................................................................................................................................................................... 2

Pholcodine .................................................................................................................................................................................... 2

Propiram ....................................................................................................................................................................................... 415,000

Psilocybin ...................................................................................................................................................................................... 2

Psilocyn ........................................................................................................................................................................................ 2

Tetrahydrocannabinols ................................................................................................................................................................. 115,000

Thiofentanyl .................................................................................................................................................................................. 2

Trimeperidine ................................................................................................................................................................................ 2

Schedule II:

1-Phenylcyclohexylamine ............................................................................................................................................................. 12

1-Piperidinocyclohexanecarbonitrile (PCC) .................................................................................................................................. 10

Alfentanil ....................................................................................................................................................................................... 8,000

Alphaprodine ................................................................................................................................................................................. 2

Amobarbital ................................................................................................................................................................................... 12

Amphetamine ................................................................................................................................................................................ 10,958,000

Cocaine ......................................................................................................................................................................................... 251,000

Codeine (for sale) ......................................................................................................................................................................... 43,248,000

Codeine (for conversion) .............................................................................................................................................................. 52,384,000

Dextropropoxyphene .................................................................................................................................................................... 121,017,000

Dihydrocodeine ............................................................................................................................................................................. 244,000

Diphenoxylate ............................................................................................................................................................................... 931,000

Ecgonine ....................................................................................................................................................................................... 36,000

Ethylmorphine ............................................................................................................................................................................... 12

Fentanyl ........................................................................................................................................................................................ 300,000

Glutethimide .................................................................................................................................................................................. 2

Hydrocodone (for sale) ................................................................................................................................................................. 21,417,000

Hydrocodone (for conversion) ...................................................................................................................................................... 20,700,000

Hydromorphone ............................................................................................................................................................................ 1,409,000

Isomethadone ............................................................................................................................................................................... 12

Levo-alphacetylmethadol (LAAM) ................................................................................................................................................ 12

Levomethorphan ........................................................................................................................................................................... 2

Levorphanol .................................................................................................................................................................................. 27,000

Meperidine .................................................................................................................................................................................... 10,168,000

Metazocine ................................................................................................................................................................................... 1

Methadone (for sale) .................................................................................................................................................................... 8,347,000

Methadone (for conversion) ......................................................................................................................................................... 0

Methadone Intermediate ............................................................................................................................................................... 9,503,000

57626 Federal Register / Vol. 65, No. 186 / Monday, September 25, 2000 / Notices

Basic class

Established

final 2000

quotas

Methamphetamine ........................................................................................................................................................................ 2,104,000

850,000 grams of levo-desoxyephedrine for use in a non-controlled, non-prescription product; 1,225,000 grams for methamphetamine for

conversion to a Schedule III product; and, 29,000 grams for methamphetamine (for sale)

Methylphenidate ........................................................................................................................................................................... 14,957,000

Morphine (for sale) ....................................................................................................................................................................... 14,706,000

Morphine (for conversion) ............................................................................................................................................................ 97,410,000

Nabilone ........................................................................................................................................................................................ 2

Noroxymorphone (for sale) ........................................................................................................................................................... 25,000

Noroxymorphone (for conversion) ................................................................................................................................................ 3,813,000

Opium ........................................................................................................................................................................................... 720,000

Oxycodone (for sale) .................................................................................................................................................................... 35,850,000

Oxycodone (for conversion) ......................................................................................................................................................... 602,000

Oxymorphone ............................................................................................................................................................................... 353,000

Pentobarbital ................................................................................................................................................................................. 24,037,000

Phencyclidine ................................................................................................................................................................................ 41

Phenmetrazine .............................................................................................................................................................................. 2

Phenylacetone .............................................................................................................................................................................. 10

Secobarbital .................................................................................................................................................................................. 22

Sufentanil ...................................................................................................................................................................................... 1,700

Thebaine ....................................................................................................................................................................................... 45,444,000

The Deputy Administrator further

orders that aggregate production quotas

for all other Schedules I and II

controlled substances included in

Sections 1308.11 and 1308.12 of Title 21

of the Code of Federal Regulations

remain at zero.

The Office of Management and Budget

has determined that notices of aggregate

production quotas are not subject to

centralized review under Executive

Order 12866. This action has been

analyzed in accordance with the

principles and criteria contained in

Executive Order 13132, and it has been

determined that this matter does not

have sufficient federalism implications

to warrant the preparation of a

Federalism Assessment.

The Deputy Administrator hereby

certifies that this action will have no

significant impact upon small entities

whose interests must be considered

under the Regulatory Flexibility Act, 5

U.S.C. 601 et seq. The establishment of

aggregate production quotas for

Schedules I and II controlled substances

is mandated by law and by international

treaty obligations. Aggregate production

quotas apply to approximately 200 DEA

registered bulk and dosage form

manufacturers of Schedules I and II

controlled substances. The quotas are

necessary to provide for the estimated

medical, scientific, research and

industrial needs of the United States, for

export requirements and the

establishment and maintenance of

reserve stocks. While aggregate

production quotas are of primary

importance to large manufacturers, their

impact upon small entities is neither

negative nor beneficial. Accordingly, the

Deputy Administrator has determined

that this action does not require a

regulatory flexibility analysis.

Dated: September 15, 2000.

Julio F. Mercado,

Deputy Administrator.

[FR Doc. 00–24554 Filed 9–22–00; 8:45 am]

BILLING CODE 4410–09–M

DEPARTMENT OF LABOR

Office of the Secretary

Submission for OMB Emergency

Review; Comment Request

September 21, 2000.

The Department of Labor has

submitted the following (see below)

information collection request (ICR),

utilizing emergency review procedures,

to the Office of Management and Budget

(OMB) for review and clearance in

accordance with the Paperwork

Reduction Act of 1995 (P.L. 104–13, 44

U.S.C. Chapter 35). OMB approval has

been requested by October 2, 2000. A

copy of this ICR, with applicable

supporting documentation, may be

obtained by calling the Department of

Labor Departmental Clearance Officer,

Ira L. Mills ((202) 693–4122).

Comments and questions about the

ICR listed below should be forwarded to

the Office of Information and Regulatory

Affairs, Attn: OMB Desk Officer for

Departmental Management, Room

10235, Washington, DC 20503.

The Office of Management and Budget

is particularly interested in comments

which:

• Evaluate whether the proposed

collection of information is necessary

for the proper performance of the

functions of the agency, including

whether the information will have

practical utility;

• Evaluate the accuracy of the

agency’s estimate of the burden of the

proposed collection of information,

including the validity of the

methodology and assumptions used;

• Enhance the quality, utility, and

clarify of the information to be

collected; and

• Minimize the burden of the

collection of information on those who

are to respond, including through the

use of appropriate automated,

electronic, mechanical, or other

technological collection techniques or

other forms of information technology,

e.g., permitting electronic submissions

of responses.

Agency: Department of Labor/

Presidential Task Force on the

Employment of Adults with Disabilities.

Title: Youth Essay Contest.

OMB Number: 1200–ONew.

Frequency: One time only.

Affected Public: Individuals or

households; Not-for-profit institutions.

Number of Respondents: 1,000.

Total Annual Responses: 1,000.

Total Burden Hours: 2,000 hours.

Total Burden Cost (capital/startup):

$0.

Total Burden Cost (operating/

maintaining): $0.

Description: In celebration of National

Disability Employment Awareness

Month in October, the 10th Anniversary

of the Americans with Disabilities Act

(ADA), and the 25th Anniversary of the

Individuals with Disabilities Education

Act (IDEA), the Presidential Task Force

on the Employment of Adults with

Disabilities is sponsoring an essay